A correction may be in store for ResMed Inc. (NYSE:RMD) shares?

In the latest session, ResMed Inc. (NYSE: RMD) closed at $234.73 up 2.37% from its previous closing price of $229.30. In other words, the price has increased by $+5.43 from its previous closing price. On the day, 914569 shares were traded. RMD stock price reached its highest trading level at $235.62 during the session, while it also had its lowest trading level at $229.63.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

For a deeper understanding of ResMed Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 162.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 440.23. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 2.90. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.

Upgrades & Downgrades

BofA Securities Upgraded its Neutral to Buy on October 20, 2022, whereas the target price for the stock was revised from $245 to $260.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 17 when Douglas Robert Andrew sold 1,500 shares for $220.43 per share. The transaction valued at 330,645 led to the insider holds 226,208 shares of the business.

Farrell Michael J. sold 5,675 shares of RMD for $1,273,269 on Jan 17. The Chief Executive Officer now owns 436,900 shares after completing the transaction at $224.36 per share. On Jan 03, another insider, PENDARVIS DAVID, who serves as the Chief Administrative Officer of the company, sold 1,500 shares for $210.07 each. As a result, the insider received 315,105 and left with 97,172 shares of the company.

Valuation Measures:

As of this moment, ResMed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.90, and their Forward P/E ratio for the next fiscal year is 32.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.27 while its Price-to-Book (P/B) ratio in mrq is 10.01.

Stock Price History:

Over the past 52 weeks, RMD has reached a high of $262.38, while it has fallen to a 52-week low of $189.40. The 50-Day Moving Average of the stock is 218.55, while the 200-Day Moving Average is calculated to be 219.67.

Shares Statistics:

For the past three months, RMD has traded an average of 580.21K shares per day and 722.1k over the past ten days. A total of 146.43M shares are outstanding, with a floating share count of 144.57M. Insiders hold about 0.70% of the company’s shares, while institutions hold 67.40% stake in the company. Shares short for RMD as of Oct 13, 2022 were 1.23M with a Short Ratio of 1.01M, compared to 1.51M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.84% and a Short% of Float of 0.96%.

Dividends & Splits

According to the company, the forward annual dividend rate for RMD is 1.76, from 1.56 in the trailing year. Against a Trailing Annual Dividend Yield of 0.68%, it implies a Forward Annual Dividend Yield of 0.75%. The stock’s 5-year Average Dividend Yield is 1.02. The current Payout Ratio is 31.60% for RMD, which recently paid a dividend on Dec 14, 2022 with an ex-dividend date of Aug 16, 2022. Stock splits for the company last occurred on Aug 30, 2010 when the company split stock in a 2:1 ratio.

Earnings Estimates

There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of $1.58 for the current quarter, with a high estimate of $1.64 and a low estimate of $1.53, while EPS last year was $1.47. The consensus estimate for the next quarter is $1.59, with high estimates of $1.63 and low estimates of $1.56.

Analysts are recommending an EPS of between $6.89 and $6.25 for the fiscal current year, implying an average EPS of $6.51. EPS for the following year is $7.32, with 10 analysts recommending between $8.4 and $6.71.

Revenue Estimates

A total of 15 analysts have provided revenue estimates for RMD’s current fiscal year. The highest revenue estimate was $4.2B, while the lowest revenue estimate was $3.74B, resulting in an average revenue estimate of $3.98B. In the same quarter a year ago, actual revenue was $3.58B, up 11.20% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $4.3B in the next fiscal year. The high estimate is $4.79B and the low estimate is $3.93B. The average revenue growth estimate for next year is up 8.10% from the average revenue estimate for this year.